Sergio Fazio, MD, PhD Current Title: VP/Chair, Scientific Council, Global Clinical Development, Regeneron Home Address: 3440 SW Downs View Terrace, Portland, OR 97221 (615) 364-5083 ( fazio@fastmail.com ) and 203 Legend Drive, Sleepy Hollow, NY 10591 (914) 255-8945 Business Address: Regeneron Pharmaceuticals，Inc。777 Old Saw Mill River Road，Tarrytown，NY 10591（914）847-7000（Sergio.fazio@regeneron.com）专业背景：Italy罗马大学的医学学位，医学驻留和代谢/内分泌奖。实验医学博士学位课程始于意大利锡耶纳大学，并在加利福尼亚大学旧金山分校的Gladstone Institutes完成。 First faculty position at UCSF as Instructor in Medicine, then joined Vanderbilt University as Assistant Professor in the Division of Endocrinology and director of the Lipid Clinic and Diagnostic Laboratory, then promoted to Associate Professor with tenure, then joined the Division of Cardiovascular Medicine as Director of the Atherosclerosis Research Unit, then promoted to full Professor with endowment (Cornelius Vanderbilt Chair) and Chief of预防心血管疾病，随后加入了俄勒冈健康与科学大学，担任首届威廉和桑贾·康纳（Sonja Connor）的授权主席预防性心脏病学和预防性心脏病学中心主任。 最后，加入了Regeneron Pharmaceuticals的全球临床开发小组，并在科学委员会中担任副总裁兼副代谢疾病主席。 轨迹：临床研究对临床研究的基础研究，以实施科学至药物开发。 成就：实验医学博士学位课程始于意大利锡耶纳大学，并在加利福尼亚大学旧金山分校的Gladstone Institutes完成。First faculty position at UCSF as Instructor in Medicine, then joined Vanderbilt University as Assistant Professor in the Division of Endocrinology and director of the Lipid Clinic and Diagnostic Laboratory, then promoted to Associate Professor with tenure, then joined the Division of Cardiovascular Medicine as Director of the Atherosclerosis Research Unit, then promoted to full Professor with endowment (Cornelius Vanderbilt Chair) and Chief of预防心血管疾病，随后加入了俄勒冈健康与科学大学，担任首届威廉和桑贾·康纳（Sonja Connor）的授权主席预防性心脏病学和预防性心脏病学中心主任。最后，加入了Regeneron Pharmaceuticals的全球临床开发小组，并在科学委员会中担任副总裁兼副代谢疾病主席。轨迹：临床研究对临床研究的基础研究，以实施科学至药物开发。成就：